State Street Corp Soligenix, Inc. Transaction History

State Street Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.4 - $5.8 $29,185 - $423,191	-72,964 Closed	0 $0
Q2 2022 Aug 15, 2022	BUY	$0.4 - $0.75 $10,237 - $19,195	25,594 Added 54.03%	72,964 $44,000
Q3 2021 Nov 15, 2021	BUY	$0.9 - $1.31 $2,250 - $3,275	2,500 Added 5.57%	47,370 $50,000
Q2 2021 Aug 16, 2021	BUY	$0.87 - $1.58 $39,036 - $70,894	44,870 New	44,870 $50,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $125M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.